SCHEMBL22326119

SCHEMBL22326119

FC(F)(F)C(c1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
CYP1A2 P05177 3/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 1/20 0.54
CYP2A6 P11509 3/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ADRA2A P08913 4/20 0.39
ADRA2B P18089 4/20 0.39
ADRA2C P18825 4/20 0.39
ADRA1A P35348 4/20 0.39
ADRA1D P25100 3/20 0.39
ADRA1B P35368 3/20 0.39
SLC6A4 P31645 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3247528 0.83 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL30344446 0.82 KDM4E (0.44) ALDH1A1CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL31360106 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL5691047 0.79 CYP2C9 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL30343954 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL25155317 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL5609979 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL5609974 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL16579379 0.79 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6
SCHEMBL5691041 0.79 CYP2C9 (0.55) ALDH1A1CYP1A2CYP2C9CYP2C19CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435185-B2 Method for producing 1,1,1-trifluoro-2,2-bisarylethane, and 1,1,1-trifluoro-2,2-bisarylethane CENTRAL GLASS COMPANY, LIMITED (JP) 2025-10-07 US disclosed
US-20220106444-A1 Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane CENTRAL GLASS COMPANY, LIMITED (JP) 2022-04-07 US disclosed
WO-2020162408-A1 METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE セントラル硝子株式会社 2020-08-13 WO disclosed
WO-2020162408-A1 METHOD FOR PRODUCING 1,1,1-TRIFLUORO-2,2-BISARYLETHANE, AND 1,1,1-TRIFLUORO-2,2-BISARYLETHANE セントラル硝子株式会社 2020-08-13 WO disclosed
US-20160271105-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2016-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220106444-A1 Method for Producing 1,1,1-Trifluoro-2,2-Bisarylethane, and 1,1,1-Trifluoro-2,2-Bisarylethane NAF1, FXR1, AFF1 ALDH1A1 624/4885CYP1A2 292/4885CYP2C9 1165/4885
US-12435185-B2 Method for producing 1,1,1-trifluoro-2,2-bisarylethane, and 1,1,1-trifluoro-2,2-bisarylethane NAF1, FXR1, AFF1 ALDH1A1 624/4885CYP1A2 292/4885CYP2C9 1165/4885
US-20160271105-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 ALDH1A1 1961/4885CYP1A2 2202/4885CYP2C9 1579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.